- Home
- CIFRW vs OSRHW Comparison
CIFRW vs OSRHW Comparison
Compare CIFRW & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIFRW
- OSRHW
- Stock Information
- Founded
- CIFRW 2020
- OSRHW N/A
- Country
- CIFRW United States
- OSRHW United States
- Employees
- CIFRW 43
- OSRHW 21
- Industry
- CIFRW Investment Bankers/Brokers/Service
- OSRHW
- Sector
- CIFRW Finance
- OSRHW
- Exchange
- CIFRW Nasdaq
- OSRHW Nasdaq
- Market Cap
- CIFRW N/A
- OSRHW N/A
- IPO Year
- CIFRW N/A
- OSRHW 2023
- Fundamental
- Price
- CIFRW $4.19
- OSRHW $0.05
- Analyst Decision
- CIFRW
- OSRHW
- Analyst Count
- CIFRW 0
- OSRHW 0
- Target Price
- CIFRW N/A
- OSRHW N/A
- AVG Volume (30 Days)
- CIFRW 67.9K
- OSRHW N/A
- Earning Date
- CIFRW 02-25-2025
- OSRHW N/A
- Dividend Yield
- CIFRW N/A
- OSRHW N/A
- EPS Growth
- CIFRW N/A
- OSRHW N/A
- EPS
- CIFRW N/A
- OSRHW N/A
- Revenue
- CIFRW $152,466,000.00
- OSRHW N/A
- Revenue This Year
- CIFRW N/A
- OSRHW N/A
- Revenue Next Year
- CIFRW N/A
- OSRHW N/A
- P/E Ratio
- CIFRW N/A
- OSRHW N/A
- Revenue Growth
- CIFRW 76.34
- OSRHW N/A
- 52 Week Low
- CIFRW $1.58
- OSRHW N/A
- 52 Week High
- CIFRW $1.69
- OSRHW N/A
- Technical
- Relative Strength Index (RSI)
- CIFRW 35.88
- OSRHW N/A
- Support Level
- CIFRW $9.89
- OSRHW N/A
- Resistance Level
- CIFRW $11.00
- OSRHW N/A
- Average True Range (ATR)
- CIFRW 2.08
- OSRHW 0.00
- MACD
- CIFRW -0.90
- OSRHW 0.00
- Stochastic Oscillator
- CIFRW 2.99
- OSRHW 0.00
About CIFRW Cipher Mining Inc. Warrant
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.